The US officially announced on Friday that White House Kovid coordinator Jeff Jaistas would loan a portion of his trusty AstraZeneca Kovid-19 vaccines to Mexico and Canada.
In the US awaiting approval of the official use of the vaccine, the US will loan approximately 4 million doses to both countries. CNN has previously reported that Mexico will receive approximately 2.5 million doses, with 1.5 million going to Canada.
“We currently have three effective vaccines that have gone through a rigorous review process authorized by the FDA. We have other processes right now, including one from AstraZeneca. As we await the results of these tests in the US, many countries have already approved AstraZeneca, but more supplies are needed. This includes Canada and Mexico.
He said, “Therefore, while balancing the need to extend the AstraZeneca vaccine approval process here in the US, along with the importance of helping to prevent the spread in other countries, we are offering a portion of our trusted AstraSeneca vaccine to Mexico.” Will loan. Canada. “
The loan, Zaders said, would allow US neighbors “to meet a significant vaccination requirement in their countries, providing immediate greater security in the North American continent.”
Patients clarified that those doses would not be taken from Americans because the vaccine is still not authorized for emergency use in the US.
“No American will live without a vaccine because of this action,” he said.
The patients were pressed by Cattellan Collins of CNN to clarify how the loan process would work. He suggested that it would follow “the structure of a loan” and the dose would be returned later in 2021 via AstraZeneca.
“The structure of a loan is what makes the most sense. And given that we’re balancing here, which is helping our global partners, while they have an important need, and we’re going to look at the results of clinical trials here in the US and FDA’s AstraZeneca action over the next several weeks Waiting, ”the patients said.
He added, “So this arrangement helps Canada and Mexico at the moment, meeting that critical need, making sure they return those doses to the company – via AstraZeneca – later.”